Article
The role of pathologists in recognition of morphologic and biologic features of genetically mutated breast cancer.
The breast journal - 1 Aug 2020
Masood Shahla
Abstract excerpt
The recent introduction of genomic medicine and emphasis on optimizing breast cancer risk reduction mortalities has provided opportunities for pathologists to partner with clinicians in advancing the diagnosis and management of breast cancer patients. The discovery of breast cancer genes BRCA1, BRCA2, and other breast cancer genes is considered a major breakthrough in the understanding of hereditary breast...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
